Literature DB >> 12969546

CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells.

Matthias Peiser1, Andreas Grützkau, Reinhard Wanner, Gerhard Kolde.   

Abstract

There is increasing evidence that ex vivo generated Langerhans cells (LCs) cannot fully substitute for their physiological counterparts in normal epidermis when studying the immunobiology of this prototype of a tissue-residing immature dendritic cell (DC). Here, we present CD1-based magnetic-activated cell-sorting (MACS) protocols for the effective isolation of human epidermal LCs. CD1c selection yielded a homogeneous population of pure and viable HLA-DR(+)/CD1a(+) DCs, with the ultrastructural features, surface antigen expression and cytokine profile, characteristic of epidermis-resident immature LCs. The immature state and functional integrity were established by allogeneic mixed lymphocyte reactions showing a weak stimulatory capacity of freshly isolated cells and upregulation upon stimulation. Characterizing the cells in more detail, we could demonstrate for the first time that normal human LCs express CXCR4, CD40 ligand (CD40L), and Fas and Fas ligand (FasL). The observed constitutive transcription of TGF-beta suggests that the viability and immature state of epidermal LCs are maintained not only by the TGF-beta production from the microenvironment, but also in an autocrine or paracrine manner. LPS and IFN-omega stimulated the expression of the inflammatory cytokines TNF-alpha and IL-1beta, and there was secretion of IL-12p70 after CD40 ligation. Remarkably, the CD1-sorted LCs showed no loss of their Birbeck granules and CD1a expression upon culturing and no spontaneous phenotypic and functional maturation into potent antigen-presenting cells (APCs). We conclude that human epidermal LCs obtained by the CD1c cell-sorting protocol are optimal candidates with which to elucidate the properties and capabilities of immature cells and to develop immunotherapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969546     DOI: 10.1016/s0022-1759(03)00257-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

Review 1.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

2.  Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream.

Authors:  Abel Torres; Leslie Storey; Makala Anders; Richard L Miller; Barbara J Bulbulian; Jizhong Jin; Shalini Raghavan; James Lee; Herbert B Slade; Woubalem Birmachu
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

3.  Quiescent innate response to infective filariae by human Langerhans cells suggests a strategy of immune evasion.

Authors:  Alexis Boyd; Sasisekhar Bennuru; Yuanyuan Wang; Vivornpun Sanprasert; Melissa Law; Damien Chaussabel; Thomas B Nutman; Roshanak Tolouei Semnani
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

4.  Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy.

Authors:  Fiorenza Rancan; Dimitrios Papakostas; Sabrina Hadam; Steffen Hackbarth; Thierry Delair; Charlotte Primard; Bernard Verrier; Wolfram Sterry; Ulrike Blume-Peytavi; Annika Vogt
Journal:  Pharm Res       Date:  2009-06-17       Impact factor: 4.200

5.  Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy.

Authors:  Manuel Hitzler; Otto Majdic; Guido Heine; Margitta Worm; Grit Ebert; Andreas Luch; Matthias Peiser
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

6.  Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study.

Authors:  Regina Fölster-Holst; Jagoda Galecka; Sigo Weißmantel; Ute Dickschat; Frank Rippke; Kerstin Bohnsack; Thomas Werfel; Katja Wichmann; Matthias Buchner; Thomas Schwarz; Annika Vogt; Jürgen Lademann; Martina C Meinke
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.